Insmed, Inc. (INSM)
124.03
-1.74
(-1.38%)
USD |
NASDAQ |
Aug 24, 16:00
124.03
0.00 (0.00%)
After-Hours: 20:00
Insmed Total Assets (Quarterly) : 2.103B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.103B |
| March 31, 2026 | 2.076B |
| December 31, 2025 | 2.265B |
| September 30, 2025 | 2.361B |
| June 30, 2025 | 2.480B |
| March 31, 2025 | 1.803B |
| December 31, 2024 | 2.025B |
| September 30, 2024 | 2.053B |
| June 30, 2024 | 1.810B |
| March 31, 2024 | 1.159B |
| December 31, 2023 | 1.330B |
| September 30, 2023 | 1.325B |
| June 30, 2023 | 1.439B |
| March 31, 2023 | 1.518B |
| December 31, 2022 | 1.656B |
| September 30, 2022 | 994.82M |
| June 30, 2022 | 1.053B |
| March 31, 2022 | 1.153B |
| December 31, 2021 | 1.244B |
| September 30, 2021 | 1.312B |
| June 30, 2021 | 1.230B |
| March 31, 2021 | 692.39M |
| December 31, 2020 | 796.16M |
| September 30, 2020 | 840.72M |
| June 30, 2020 | 885.36M |
| Date | Value |
|---|---|
| March 31, 2020 | 676.52M |
| December 31, 2019 | 742.30M |
| September 30, 2019 | 763.12M |
| June 30, 2019 | 802.78M |
| March 31, 2019 | 595.92M |
| December 31, 2018 | 604.56M |
| September 30, 2018 | 661.51M |
| June 30, 2018 | 724.24M |
| March 31, 2018 | 773.15M |
| December 31, 2017 | 462.05M |
| September 30, 2017 | 506.21M |
| June 30, 2017 | 165.64M |
| March 31, 2017 | 200.66M |
| December 31, 2016 | 237.96M |
| September 30, 2016 | 276.64M |
| June 30, 2016 | 299.68M |
| March 31, 2016 | 327.71M |
| December 31, 2015 | 356.56M |
| September 30, 2015 | 385.74M |
| June 30, 2015 | 408.51M |
| March 31, 2015 | 206.15M |
| December 31, 2014 | 230.86M |
| September 30, 2014 | 235.44M |
| June 30, 2014 | 150.11M |
| March 31, 2014 | 166.62M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| United Therapeutics Corp. | 7.220B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Biogen, Inc. | 32.09B |
| Gilead Sciences, Inc. | 49.36B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.345B |
| Shareholders Equity (Quarterly) | 757.49M |
| Debt to Equity Ratio | 0.9865 |
| Current Ratio | 3.724 |
| Net Debt Paydown Yield | 0.48% |